PMV Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview

Pmv Pharmaceuticals

24/02/2025 21:25

* PMV Pharmaceuticals Inc  PMVP.OQ   PMVP.O  is expected
to show
no change in quarterly revenue when it reports  results on
February 26 (estimated) for the period ending December 31 2024
    * 
    * ​LSEG's mean analyst estimate for PMV Pharmaceuticals Inc
is for
a loss of 38 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for PMV
Pharmaceuticals Inc is $6.00​, above​ its last closing price
of $1.41. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2024  -0.36       -0.35      -0.37     Missed  -5.4
 Jun. 30 2024  -0.35       -0.35      -0.02     Beat    94.3
 Mar. 31 2024  -0.35       -0.36      -0.30     Beat    16.8​
 Dec. 31 2023  -0.38       -0.39      -0.31     Beat    19.7
 ​​Sep.        -0.45       -0.45      -0.34     Beat    23.8
 30 2023                                                
 Jun. 30 2023  -0.46       -0.47      -0.38     Beat    20​
 Mar. 31 2023  -0.44       -0.46      -0.42     Beat    8.4
 Dec. 31 2022  -0.44       -0.44      -0.43     Beat    1.9
 This summary was machine generated February 24 at 21:25 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)